207 related articles for article (PubMed ID: 25180698)
1. Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study.
Harrison C; Britt H; Garland S; Conway L; Stein A; Pirotta M; Fairley C
PLoS One; 2014; 9(9):e105967. PubMed ID: 25180698
[TBL] [Abstract][Full Text] [Related]
2. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
[TBL] [Abstract][Full Text] [Related]
3. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program.
Ali H; Guy RJ; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Donovan B
BMC Infect Dis; 2013 Mar; 13():140. PubMed ID: 23506489
[TBL] [Abstract][Full Text] [Related]
4. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18.
Chow EPF; Carter A; Vickers T; Fairley CK; McNulty A; Guy RJ; Regan DG; Grulich AE; Callander D; Khawar L; Machalek DA; Donovan B
Lancet Infect Dis; 2021 Dec; 21(12):1747-1756. PubMed ID: 34339639
[TBL] [Abstract][Full Text] [Related]
5. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B
Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790
[TBL] [Abstract][Full Text] [Related]
7. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
[TBL] [Abstract][Full Text] [Related]
8. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
9. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
Canvin M; Sinka K; Hughes G; Mesher D
Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
[TBL] [Abstract][Full Text] [Related]
10. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
Perkins RB; Legler A; Hanchate A
Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
[TBL] [Abstract][Full Text] [Related]
11. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males.
Korostil IA; Ali H; Guy RJ; Donovan B; Law MG; Regan DG
Sex Transm Dis; 2013 Nov; 40(11):833-5. PubMed ID: 24113401
[TBL] [Abstract][Full Text] [Related]
12. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
Westra TA; Stirbu-Wagner I; Dorsman S; Tutuhatunewa ED; de Vrij EL; Nijman HW; Daemen T; Wilschut JC; Postma MJ
BMC Infect Dis; 2013 Feb; 13():75. PubMed ID: 23390964
[TBL] [Abstract][Full Text] [Related]
13. What can surveillance of genital warts tell us?
Fairley CK; Donovan B
Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
[TBL] [Abstract][Full Text] [Related]
14. Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011.
Liu B; Donovan B; Brotherton JM; Saville M; Kaldor JM
Sex Transm Infect; 2014 Nov; 90(7):532-7. PubMed ID: 24570485
[TBL] [Abstract][Full Text] [Related]
15. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
[TBL] [Abstract][Full Text] [Related]
16. Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study.
Cocchio S; Baldovin T; Bertoncello C; Buja A; Furlan P; Saia M; Baldo V
BMC Infect Dis; 2017 Apr; 17(1):249. PubMed ID: 28381294
[TBL] [Abstract][Full Text] [Related]
17. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
Cocchio S; Prandi GM; Furlan P; Bertoncello C; Fonzo M; Saia M; Baldovin T; Baldo V
BMC Infect Dis; 2020 Nov; 20(1):857. PubMed ID: 33208109
[TBL] [Abstract][Full Text] [Related]
18. The Australian experience with the human papillomavirus vaccine.
Garland SM
Clin Ther; 2014 Jan; 36(1):17-23. PubMed ID: 24417782
[TBL] [Abstract][Full Text] [Related]
19. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
Oliphant J; Perkins N
N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
[TBL] [Abstract][Full Text] [Related]
20. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.
Fairley CK; Hocking JS; Gurrin LC; Chen MY; Donovan B; Bradshaw CS
Sex Transm Infect; 2009 Dec; 85(7):499-502. PubMed ID: 19837728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
